Gunter Schumann, MD
Professor and Chair of Biological Psychiatry
The IMAGEN team in London is led by the study Principal Investigator Professor Gunter Schumann. Prof. Schumann is a Psychiatrist and a Professor of Addiction Biology.
Erin Burke Quinlan, PhD
Dr. Quinlan holds a PhD in Neuroimaging and Biomedical Sciences and is a Lecturer at King’s College London. Dr. Quinlan supervises the recruitment that takes place at the London site and oversees the progress of all the European study sites too.
Reader of Genetics at the Department of Social Genetic & Developmental Psychiatry at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London.
Over the course of her career Sylvane has applied expertise in genetics and molecular and cell biology to understand how gene activity controls biological functions in organisms and systems of increasing complexity, from individual cells and unicellular organisms to organs, such as the mammary gland, and finally to the human brain.
Since little is known about the genetic bases of brain structure and function, she has combined the tremendous advantages of magnetic resonance imaging (MRI) with genetics and molecular biological approaches to investigate brain-behaviour relationships and identify genes influencing brain development and function, focusing on typically developing individuals. She applies MRI to discover the genetic roots of neuroanatomic, neurophysiological and cognitive traits that may be disrupted in individuals suffering from major mental illnesses. Another aspect of her work is aimed at overall better understanding of the etiology of addiction to alcohol and other drugs and her research helps defining risk factors for alcohol-use disorders later in life, which is fundamental for the prevention of alcohol abuse in adolescents and treatment of alcoholism, both major unmet challenges affecting our health care system and society alike.
The SGDP Centre’s mission is to undertake research on the impact and interplay between genetic, environmental and developmental factors, and their roles in the causal processes underlying the origins and course of multifactorial mental disorders; to consider the implications for clinical practice and public health policy; and to train others in the methodologies involved.
The department’s focus is on common psychiatric disorders that emerge in childhood such as mood disorders (anxiety and depression), ‘externalising’ disorders (disruptive behaviour including hyperactivity and addictions), and cognitive disorders (learning disabilities and the autistic spectrum). Amongst the academics within the centre are extraordinarily diverse and multi-disciplinary expertise in subjects such as psychiatry, social psychology, psychopathology, personality traits, quantitative and statistical genetics, epigenetics, bioinformatics, molecular genetics, quantitative genetics, EEG/ERP, developmental psychology and environmental effects.
The Institute of Psychiatry, Psychology & Neuroscience (IoPPN) is Europe’s largest centre for research and post-graduate education in psychiatry, psychology, basic and clinical neuroscience. World renowned for the quality of our research in psychiatry and psychology, we are the most cited research centre outside the US, and the second most cited in the world as ranked by Thomson ISI Essential Science Indicators. In the 2008 Research Assessment Exercise we were judged to have the highest research power of any UK institution within the areas of psychiatry, neuroscience and clinical psychology. Our world-class research-led learning experience attracts the very best students from around the world. Our students enjoy unrivalled learning opportunities, supported by strong partnerships with NHS Trusts, industry and healthcare organisations.
Send us a message:
Tel: + 44 207 848 5395
Fax: +44 807 848 0866
Tel: +44 207 848 0824
Facebook: IMAGEN Facebook